GeneTwin: A BioTech/DeepTech platform that uses high-fidelity machine learning models to simulate CRISPR base editor activity in silico. It predicts off-target effects and editing efficiency with 95% accuracy, allowing labs to 'pre-screen' thousands of guide RNAs digitally, reducing wet-lab iterations by 80% and cutting preclinical costs by $5M per candidate.
Validated on That's Missing platform | Status: Active Opportunity
Market Catalyst & News Trigger
"Global shortage of CRISPR base editors due to new biosafety guidelines requiring offline validation"
The Workflow Friction
Gene therapy startups are facing 12-month delays in clinical trials because they cannot validate the specificity of their CRISPR base editors offline. Current in-vitro validation is slow and prone to false negatives, leading to wasted $10M+ in preclinical work. Labs lack a standardized, high-throughput digital twin for testing editor efficiency before wet-lab execution.
Problem Summary
Real-world problem signal validation.
One-Shot MVP Builder Blueprint (48 Hours)
Dashboard: Guide RNA Screening Interface. Core Flow: Input Target DNA Sequence -> Generate 10,000 potential Guide RNAs -> ML Model predicts specificity and efficiency score -> Rank top 100 candidates -> Export CSV for wet-lab validation -> Track experimental results to retrain model.
Recommended Developer Tech Stack
- Python
- PyTorch
- FastAPI
- React
- S3